Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1,767,364,935
-
Total 13F shares
-
1,079,455,027
-
Share change
-
+17,917,820
-
Total reported value
-
$165,245,597,123
-
Put/Call ratio
-
83%
-
Price per share
-
$153.16
-
Number of holders
-
2,945
-
Value change
-
+$2,647,703,611
-
Number of buys
-
1,218
-
Number of sells
-
1,419
Institutional Holders of AbbVie Inc. - Common Stock (ABBV) as of Q2 2022
As of 30 Jun 2022,
AbbVie Inc. - Common Stock (ABBV) was held by
2,945 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,079,455,027 shares.
The largest 10 holders included
VANGUARD GROUP INC, STATE STREET CORP, JPMORGAN CHASE & CO, Capital International Investors, PRICE T ROWE ASSOCIATES INC /MD/, GEODE CAPITAL MANAGEMENT, LLC, Capital Research Global Investors, MORGAN STANLEY, NORTHERN TRUST CORP, and Bank of New York Mellon Corp.
This page lists
2,975
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.